BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:177Lu-DWJ155 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of 177Lu-DWJ155\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07660055-2303@assetmemo.bio
DTSTAMP:20261121T005653Z
DTSTART;VALUE=DATE:20320524
DTEND;VALUE=DATE:20320525
SUMMARY:177Lu-DWJ155: Phase 1 readout est. (NCT07660055)
DESCRIPTION:177Lu-DWJ155\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: St
 udy of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors\
 nEstimated primary completion: 24 May 2032. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/177lu-dwj155#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07660055
URL:https://assetmemo.bio/drug/177lu-dwj155#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
